BioSpace News Archive

Business

Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the third quarter 2023 following the close of market on Thursday, November 9, 2023.

October 5, 2023
·
1 min read
Business

IDEXX Laboratories to Release 2023 Third Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens.

October 5, 2023
·
1 min read
Business

Envista Schedules Third Quarter 2023 Earnings Call

Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its third quarter 2023 on Wednesday, November 1, 2023.

October 5, 2023
·
2 min read
Vivoryon Therapeutics N.V. Announces Virtual R&D Event with Key Opinion Leaders and Upcoming Conference Participation

Vivoryon Therapeutics N.V. announced its plans to host a Virtual R&D Event with Key Opinion Leaders on October 17, 2023.

October 5, 2023
·
3 min read
Biotech Beach

TETROUS, INC. ANNOUNCES ISSUE OF AN ADDITIONAL U.S. PATENT RELATED TO ENFIX™ DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES

Tetrous, Inc., a regenerative medicine company, today announced that another patent (U.S. Patent Number 11,759,548) specifically related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been issued by the United States Patent and Trademark Office.

October 5, 2023
·
2 min read
Biotech Bay

Ultragenyx to Present Pipeline Update at Analyst Day on Monday, October 16, 2023

Ultragenyx Pharmaceutical Inc. will host an Analyst Day at 8:30 a.m. ET on Monday, October 16, 2023.

October 5, 2023
·
3 min read
BioForest

Umoja Biopharma to Present at the 2023 Cell & Gene Meeting on the Mesa

Umoja Biopharma, Inc., a transformative immuno-oncology company creating off-the-shelf treatments for solid and hematologic cancers, announced that the Company will present at the 2023 Cell & Gene Meeting on the Mesa to be held October 10-12, 2023, in Carlsbad, California, and virtually.

October 5, 2023
·
3 min read
Business

T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report preliminary financial results for the third quarter 2023 and business updates after market close on Thursday, October 12, 2023.

October 5, 2023
·
1 min read
Policy

Innate Pharma Provides Update on Lacutamab Clinical Program

Innate Pharma SA announced that the U.S. Food and Drug Administration has placed a partial clinical hold on the lacutamab IND leading to a pause in new patient enrollment to the Company’s ongoing lacutamab trials IPH4102-201 and 102.

October 5, 2023
·
7 min read
Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 5, 2023
·
5 min read